The Oncology Institute, Inc. (NASDAQ:TOI) Short Interest Up 70.1% in November

The Oncology Institute, Inc. (NASDAQ:TOI) was the recipient of a significant increase in short interest in November. As of November 15th, there was short interest totalling 421,900 shares, an increase of 70.1% from the October 31st total of 248,000 shares. Based on an average daily trading volume, of 1,010,000 shares, the short-interest ratio is presently 0.4 days. Approximately 1.1% of the shares of the stock are short sold.

Hedge Funds Weigh In On Oncology Institute

A number of large investors have recently modified their holdings of TOI. Tiff Advisory Services LLC lifted its position in shares of Oncology Institute by 235.1% during the second quarter. Tiff Advisory Services LLC now owns 1,418,685 shares of the company’s stock worth $653,000 after purchasing an additional 995,280 shares in the last quarter. Renaissance Technologies LLC lifted its position in shares of Oncology Institute by 142.3% during the second quarter. Renaissance Technologies LLC now owns 339,400 shares of the company’s stock worth $156,000 after purchasing an additional 199,300 shares in the last quarter. Finally, HighTower Advisors LLC lifted its position in shares of Oncology Institute by 190.8% during the third quarter. HighTower Advisors LLC now owns 81,362 shares of the company’s stock worth $27,000 after purchasing an additional 53,382 shares in the last quarter. 36.86% of the stock is currently owned by institutional investors and hedge funds.

Oncology Institute Price Performance

NASDAQ:TOI traded down $0.01 on Friday, reaching $0.16. The stock had a trading volume of 1,117,426 shares, compared to its average volume of 416,743. Oncology Institute has a 1-year low of $0.13 and a 1-year high of $2.50. The stock has a fifty day moving average price of $0.28 and a 200-day moving average price of $0.40. The company has a market capitalization of $12.24 million, a P/E ratio of -0.21 and a beta of 0.60. The company has a quick ratio of 2.27, a current ratio of 2.49 and a debt-to-equity ratio of 5.91.

About Oncology Institute

The Oncology Institute, Inc, an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services.